Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil for Colonoscopy Sedation
NCT03037892Completed
- Sponsor
- King Hamad University Hospital
- Start
- Jun 2015
- Primary completion
- May 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of remifentanil in colonoscopy (3 arms), sponsored by King Hamad University Hospital. Primary endpoints: Recovery Time, Propofol consumption and 2 more. Started Jun 2015; status: completed.
02
Drugs
remifentanil
03
Conditions
colonoscopy
Beyond the preview
Go deeper on NCT03037892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03037892.